New animal study finds glyphosate and Roundup linked to rare, fatal cancers in multiple organs—even at doses legally defined as “safe” by U.S. and EU regulators.
NICOLAS HULSCHER, MPH
The study titled, Carcinogenic effects of long-term exposure from prenatal life to glyphosate and glyphosate-based herbicides in Sprague–Dawley rats, was just published in the journal Environmental Health:
Background
Glyphosate-based herbicides (GBHs) are the world’s most widely used weed control agents. Public health concerns have increased since the International Agency for Research on Cancer (IARC) classified glyphosate as a probable human carcinogen in 2015. To further investigate the health effects of glyphosate and GBHs, the Ramazzini Institute launched the Global Glyphosate Study (GGS), which is designed to test a wide range of toxicological outcomes. Reported here are the results of the carcinogenicity arm of the GGS.
Methods
Glyphosate and two GBHs, Roundup Bioflow used in the European Union (EU) and RangerPro used in the U.S., were administered to male and female Sprague–Dawley (SD) rats, beginning at gestational day 6 (via maternal exposure) through 104 weeks of age. Glyphosate was administered through drinking water at three doses: the EU acceptable daily intake (ADI) of 0.5 mg/kg body weight/day, 5 mg/kg body weight/day and the EU no-observed adverse effect level (NOAEL) of 50 mg/kg body weight/day. The two GBH formulations were administered at the same glyphosate-equivalent doses.
Results
In all 3 treatment groups, statistically significant dose-related increased trends or increased incidences of benign and malignant tumors at multiple anatomic sites were observed compared to historical and concurrent controls. These tumors arose in haemolymphoreticular tissues (leukemia), skin, liver, thyroid, nervous system, ovary, mammary gland, adrenal glands, kidney, urinary bladder, bone, endocrine pancreas, uterus and spleen (hemangiosarcoma). Increased incidences occurred in both sexes. Most of these involved tumors that are rare in SD rats (background incidence < 1%) with 40% of leukemias deaths in the treated groups occurring before 52 weeks of age and increased early deaths were also observed for other solid tumors.
Conclusions
Glyphosate and GBHs at exposure levels corresponding to the EU ADI and the EU NOAEL caused dose-related increases in incidence of multiple benign and malignant tumors in SD rats of both sexes. Early-life onset and mortality were observed for multiple tumors. These results provide robust evidence supporting IARC’s conclusion that there is “sufficient evidence of carcinogenicity [of glyphosate] in experimental animals”. Furthermore, our data are consistent with epidemiological evidence on the carcinogenicity of glyphosate and GBHs.
Now, let’s dive into their study design and major findings.
Study Design
- Subjects: 1,020 Sprague–Dawley rats (510 males, 510 females)
- Exposure: Began in utero (gestational day 6) and continued for 104 weeks (2 years)
- Tested Substances:
- Pure glyphosate
- Roundup Bioflow (EU formulation without POEA surfactants)
- RangerPro (U.S. formulation with POEA surfactants)
- Doses: Equivalent to the European Union Acceptable Daily Intake (0.5 mg/kg/day), an intermediate level (5 mg/kg/day), and the European Union No Observed Adverse Effect Level (50 mg/kg/day)
Major Findings
1. Significant Dose-Dependent Increases in Tumors
- Tumors observed in multiple organs, including:
- Leukemia (lymphoblastic, monocytic, myeloid)
- Skin (e.g., squamous cell papillomas, keratoacanthomas, trichoepitheliomas)
- Liver (hepatocellular carcinomas)
- Thyroid (follicular and C-cell carcinomas)
- Bone (chondromas, osteomas, and osteosarcomas)
- Pancreas, adrenals, uterus, and central/peripheral nervous system
2. Early-Onset Leukemia
- 40% of leukemias in treated animals occurred before 1 year of age
- Control animals had zero cases of leukemia
- Historical controls showed leukemia incidence <1% and no early deaths
3. Rare Tumors Elevated
- Multiple tumors with <1% historical control prevalence were significantly increased
- Includes: malignant Schwannomas, malignant granular cell brain tumors, trichoepitheliomas, and pancreatic islet cell carcinomas
4. Consistent Across Formulations
- Both glyphosate alone and GBH formulations (Roundup Bioflow and RangerPro) increased tumor incidence
- RangerPro (with POEA) often showed stronger carcinogenic trends than Roundup Bioflow
These experimental findings are consistent with a study by Zhang et al, who found a statistically significant association between glyphosate exposure and increased risk of non-Hodgkin lymphoma (NHL) in humans. Their 2019 meta-analysis pooled data from over 65,000 participants across six studies—including more than 7,000 NHL cases—and reported a 41% increased risk of NHL among those with the highest glyphosate exposure:
.
Together, these animal and human data provide strong evidence of glyphosate’s carcinogenic potential and underscore the urgent need to eliminate its use entirely and replace it with demonstrably non-carcinogenic alternatives.
Aside from cancer, glyphosate has also been linked to neurodevelopment disorders and autism:
Epidemiologist and Foundation Administrator, McCullough Foundation
www.mcculloughfnd.org
Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content
References
Panzacchi S, Tibaldi E, De Angelis L, et al. Carcinogenic effects of long-term exposure from prenatal life to glyphosate and glyphosate-based herbicides in Sprague-Dawley rats. Environ Health. 2025;24(1):36. Published 2025 Jun 10. doi:10.1186/s12940-025-01187-2
Zhang L, Rana I, Shaffer RM, Taioli E, Sheppard L. Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma: A meta-analysis and supporting evidence. Mutat Res Rev Mutat Res. 2019;781:186-206. doi:10.1016/j.mrrev.2019.02.001
This article (World’s Top Herbicide Linked to Over 10 Distinct Cancers at “Safe” Doses in Landmark Study) was created and published by Nicolas Hulscher, MPH and is republished here under “Fair Use”
Featured image: Twitter
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of The Liberty Beacon Project.
Leave a Reply